Analysis of Sasang Constitutional Medicine as an Optimal Preventive Care Strategy for Hemophilia Patients.

Introduction. Medical improvements have allowed hemophilia patients to anticipate an increased quality of life and life expectancy similar to that of the general population. Analysis of the potential disease symptoms of hemophilia patients based on a survey of Sasang Constitutional Medicine (SCM) is important for optimal preventive care and adjunctive therapy to avoid life-threating complications. AIM: To predict potential disease symptoms from the viewpoint of SCM as a preventive care strategy for hemophilia patients. METHODS: Sixty-one hemophilia patients responded to a survey on Sasang constitutional classification, hemophilia disease pattern, and original symptoms. RESULTS: In terms of SCM type, the 61 of hemophilia patients included 37 Tae-Eum (60.7%), 18 So-Yang (29.5%), and 6 So-Eum (12.5%). Hemophilia was found to be higher in Tae-Eum type and lower in So-Yang and So-Eum types, while considering the distributional rate of Korean Sasang types. Most of the patients with Tae-Eum type had Joyeol or Ganyeol. Furthermore, the incidences of diabetes and high blood pressure were greater in Tae-Eum type than in those of other types. CONCLUSION: In order to increase the quality of life and overall life expectancy, hemophilia patients with Tae-Eum type should be treated through management according to SCM along with medicine against hemophilia as long-term preventive care. Diabetes and high blood pressure should be regularly monitored in patients with Tae-Eum type.

[Haemophilia in the German risk adjustment scheme]. / Die Hämophilie im morbiditätsorientierten Risikostrukturausgleich.

Haemophilia presents a challenge to every risk adjustment scheme even if it uses diagnostical or pharmaceutical data. The German adjustment scheme developed by the Bundesversicherungsamt realizes fairly cost homogenous groups for many expensive diseases. It does not regard haemophilia. This holds true for the original classification system (grouper) from 2009 and for the improved classification procedure in 2010. The extreme peak costs that can originate from haemophilia cases can present a existential risk for small health plans. The chances to form cost-homogeneous subgroups of the haemophilia disease by more specific coding or other measures seem low because of the small number of cases affected by this disease. The complementary (re-)installation of a expenditure-oriented risk sharing is regarded as suited for improvement of the performance of the German risk adjustment scheme. This also corresponds to international experience and practice.

Homoeopathy in the treatment of haemophilia

Six patients with haemophilia were treated with homoeopathic medicines. A rational attempt has been made to improve their general health, cope with side effects of Factor VIII, cut down the bleeding episodes and reduce the amount of Factor VIII needed. This has necessitated a search of the homoeopathic literature (British Homoeopathic Journal) and a study of the repertories and materia medicas. Each patient treated has had aspects of his health improved, and the overall impression is that less Factor VIII was needed

Manejo odontoestomatológico del hemofílico / odontostomatological management of the hemophilic patient

Se tratan brevemente los aspectos más salientes de la hemofilia, y los que condicionan una acumulación de enfermedad bucodental no tratada en los individuos afectados. Se presentan algunos conceptos básicos para encarar su asistencia odontológica, insistiendo sobre la importancia del trabajo en equipo. Se detallan las precauciones a emplear en cada paso para las actividades más comunes en odontoestomatología. Se concluye que la aplicación de estos principios permite la realización de tratamiento ambulatorio que incluye la exodoncia, con disminución de costos y riesgos